(1) In this article published in the January 2009 issue of Neoplasia, the HhAntag691 was obtained from Genentech, San Francisco, CA, and is not structurally equivalent to GDC-0449 as suggested in this contribution.
References
- 1.Zhang Y, Laterra J, Pomper MG. The hedgehog pathway inhibitor HhAntag691 is a potential inhibitor of ABCG2/BCRP and ABCB1/Pgp. Neoplasia. 2009;11:96–101. doi: 10.1593/neo.81264. [DOI] [PMC free article] [PubMed] [Google Scholar]